Spirulina Market by Type (Arthrospira Platensis and Arthrospira Maxima), Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), and Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent): Global Opportunity Analysis and Industry Forecast, 2020–2027
- ALL4621569
- 246 Pages
- April 2021
- Medical Devices
Spirulina is a natural algae powder known as cyanobacteria that includes potent level of proteins, antioxidants, and vitamin B and other nutrients. It exhibits various benefits such as lowering of LDL and triglyceride levels. It also exhibits anticancer properties, helps reduce blood pressure, is effective against anemia, and improves muscle strength.
Spirulina is used in various applications, such as food & beverages, dietary supplements, pharmaceuticals, animal & aquaculture, and cosmetic & personal care industry. In the last two years, multiple products were launched in the food & beverage industry in which it was used as a primary ingredient. Natural blue and green color produced from it is in high demand, and witnessed a strong market growth in the last two years.
The increase in use of spirulina as a dietary food supplement, owing to its high nutritional content is the major factor that drives the growth of the spirulina market. Furthermore, increase in adoption of healthy food in developed countries fuel the market growth in the food & beverages sector. The rise in prevalence of cancer, cardiovascular diseases, immune diseases, and other diseases boosts the demand for spirulina among its end users.
Furthermore, increase in healthcare expenditure and rise in disposable income among the population is anticipated to foster the market growth. However, limited resource of spirulina as it is extracted from freshwater sources that are available in very few areas hinders the market growth. Emerging economies such as India, China, Mexico, and Brazil are anticipated to provide new opportunities for the market growth during the forecast period.
The spirulina market is segmented into type, application, drug formulation, and region. By type, the market is bifurcated into Arthrospira Platensis and Arthrospira Platensis. By application, it is categorized into nutraceuticals, cosmetics, food & beverages, agriculture, feed, and others. By drug formulation, it is categorized into powder, tablet & capsule, liquid, and granule & gelling agent. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The report provides a comprehensive analysis of the key players operating in the global spirulina market. These players include Cyanotech Corporation, DIC Corporation, Dongtai City Spirulina Bio-engineering Co., Ltd., Algenol Biofuels Inc., Prolgae, Sensient Technologies Corporation, Parry Neutraceuticals, DDW Inc., Naturex S.A., and Algatec.
The other players operating in the global spirulina market include GNC Holdings, Inc., Now Health Group Inc, Fuqing King Dnarmsa Spirulina Co., Fraken Biochem Co., Ltd., and Far East Bio-Tec Co. Ltd.
Key benefits for stakeholders
• The study presents an in-depth analysis of the global spirulina market along with the current trends and future estimations from 2019 to 2027 to elucidate the imminent investment pockets.
• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.
• Identification of factors instrumental in changing the market scenario, rise in opportunities, and recognition of key players that can influence the market on a global and regional scale are provided in the report.
• Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the market.
Key Market Segments
By Type
• Arthrospira Platensis
• Arthrospira Maxima
By Application
• Nutraceuticals
• Food & Beverages
• Cosmetics
• Animal Feed
• Others
By Formulation
• Powder
• Tablet & Capsule
• Liquid
• Granule & Gelling Agent
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
Italy
UK
Spain
Rest of Europe
o Asia-Pacific
China
Japan
India
Australia
Rest of Asia-Pacific
o LAMEA
• Brazil
• South Africa
• Rest of LAMEA
List of key players profiled in the report
• Cyanotech Corporation
• DIC Corporation
• Cabassi & Giuriati SpA
• DDW
• DÖHLER GmbH
• Dongtai City Spirulina Bio-engineering Co., Ltd.
• Echlorial
• E.I.D. Parry Limited
• Givaudan international SA
• Prolgae Spirulina Supplies Pvt. Ltd.
• Dongtai City Spirulina Bio-engineering Co., Ltd.
• Algenol Biofuels Inc.
• Pond Technologies Inc
• Sensient Technologies Corporation
List of the other key players (not included in the report) GNC Holdings, Inc., Now Health Group Inc, Fuqing King Dnarmsa Spirulina Co., Fraken Biochem Co., Ltd., and Far East Bio-Tec Co. Ltd.
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings
2.1.1.Top investment pockets
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Parent Market Overview
3.3.Key Forces Shaping Spirulina Market
3.3.1.Moderate bargaining power of suppliers
3.3.2.High bargaining power of buyers
3.3.3.High threat of new entrants
3.3.4.Moderate threat of substitutes
3.3.5.High intensity of rivalry
3.4.Pricing Analysis
3.4.1.Pricing Analysis, By Region, 2019 & 2027
3.5.Market evolution/Industry roadmap
3.6.Patent Analysis
3.6.1.By Region (2012-2020)
3.6.2.By Applicant
3.6.3.By Year
3.7.Market share analysis
3.8.Value Chain Analysis
3.9.Impact of government regulations on the global spirulina market
3.10.Industry pain point analysis
3.11.Case Studies
3.11.1.Case Study
3.12.Market trends
3.12.1.U.S.
3.12.2.China
3.13.False perception on the use of spirulina
3.14.How the companies have reacted to the negative information
3.15.Marketing strategies for production segments
3.16.Trends for consumption in distinct European market
3.17.Use of spirulina for animal feeding
3.18.Market dynamics
3.18.1.Drivers
3.18.1.1.Increase in demand for natural ingredient
3.18.1.2.Promotion of the production of spirulina by government
3.18.1.3.R&D of spirulina as commercial products
3.18.2.Restraints
3.18.2.1.Impact on spirulina production due to climate change
3.18.3.Opportunities
3.18.3.1.Untapped markets in the developing countries
3.18.3.2.Easy to cultivate due to development in cultivation technology
3.19.Impact Analysis of COVID-19 on Spirulina Market
CHAPTER 4:SPIRULINA MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast, by consumption side
4.1.2.Market size and forecast, by production side
4.2.Arthrospira Platensis
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by consumption side
4.2.3.Market size and forecast, by production side
4.2.4.Market analysis, by country
4.3.Arthrospira maxima
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by consumption side
4.3.3.Market size and forecast, by Production side
4.3.4.Market analysis, by country
CHAPTER 5:SPIRULINA MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast, by consumption side
5.1.2.Market size and forecast, by production side
5.2.Nutraceuticals
5.2.1.Key market trends and opportunities
5.2.2.Market size and forecast, by consumption side
5.2.3.Market size and forecast, by production side
5.2.4.Market analysis, by country
5.3.Cosmetics
5.3.1.Key market trends and opportunities
5.3.2.Market size and forecast, by consumption side
5.3.3.Market size and forecast, by production side
5.3.4.Market analysis, by country
5.4.Food & beverages
5.4.1.Key market trends and opportunities
5.4.2.Market size and forecast, by consumption side
5.4.3.Market size and forecast, by production side
5.4.4.Market analysis, by country
5.5.Animal Feed
5.5.1.Key market trends and opportunities
5.5.2.Market size and forecast, by consumption side
5.5.3.Market size and forecast, by production side
5.5.4.Market analysis, by country
5.6.Other Applications
5.6.1.Key market trends and opportunities
5.6.2.Market size and forecast, by consumption side
5.6.3.Market size and forecast, by production side
5.6.4.Market analysis, by country
CHAPTER 6:SPIRULINA MARKET, BY FORMULATION
6.1.Overview
6.1.1.Market size and forecast, by consumption side
6.1.2.Market size and forecast, by production side
6.2.Powder
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by consumption side
6.2.3.Market size and forecast, by production side
6.2.4.Market analysis, by country
6.3.Tablet & capsule
6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast, by consumption side
6.3.3.Market size and forecast, by production side
6.3.4.Market analysis, by country
6.4.Liquid
6.4.1.Key market trends and opportunities
6.4.2.Market size and forecast, by consumption side
6.4.3.Market size and forecast, by production side
6.4.4.Market analysis, by country
6.5.Granule & gelling agent
6.5.1.Key market trends and opportunities
6.5.2.Market size and forecast, by consumption side
6.5.3.Market size and forecast, by production side
6.5.4.Market analysis, by country
CHAPTER 7:SPIRULINA MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.1.2.Market size and forecast, by production side
7.2.North America
7.2.1.Key market trends and opportunities
7.2.2.North America market size and forecast, by type
7.2.3.North America market size and forecast, by application
7.2.4.North America market size and forecast, by formulation
7.2.5.North America market size and forecast, by country
7.2.5.1.U.S. market size and forecast, by type
7.2.5.2.U.S. market size and forecast, by application
7.2.5.3.U.S. market size and forecast, by formulation
7.2.5.4.Canada market size and forecast, by type
7.2.5.5.Canada market size and forecast, by application
7.2.5.6.Canada market size and forecast, by formulation
7.2.5.7.Mexico market size and forecast, by type
7.2.5.8.Mexico market size and forecast, by application
7.2.5.9.Mexico market size and forecast, by formulation
7.3.Europe
7.3.1.Key market trends and opportunities
7.3.2.Europe market size and forecast, by type
7.3.3.Europe market size and forecast, by application
7.3.4.Europe market size and forecast, by formulation
7.3.5.Europe market size and forecast, by country
7.3.5.1.Germany market size and forecast, by type
7.3.5.2.Germany market size and forecast, by application
7.3.5.3.Germany market size and forecast, by formulation
7.3.5.4.France market size and forecast, by type
7.3.5.5.France market size and forecast, by application
7.3.5.6.France market size and forecast, by formulation
7.3.5.7.UK market size and forecast, by type
7.3.5.8.UK market size and forecast, by application
7.3.5.9.UK market size and forecast, by formulation
7.3.5.10.Italy market size and forecast, by type
7.3.5.11.Italy market size and forecast, by application
7.3.5.12.Italy market size and forecast, by formulation
7.3.5.13.Spain market size and forecast, by type
7.3.5.14.Spain market size and forecast, by application
7.3.5.15.Spain market size and forecast, by formulation
7.3.5.16.Rest of Europe market size and forecast, by type
7.3.5.17.Rest of Europe market size and forecast, by application
7.3.5.18.Rest of Europe market size and forecast, by formulation
7.4.Asia-Pacific
7.4.1.Key market trends and opportunities
7.4.2.Asia-Pacific market size and forecast, by type
7.4.3.Asia-Pacific market size and forecast, by application
7.4.4.Asia-Pacific market size and forecast, by formulation
7.4.5.Asia-Pacific market size and forecast, by country
7.4.5.1.Japan market size and forecast, by type
7.4.5.2.Japan market size and forecast, by application
7.4.5.3.Japan market size and forecast, by formulation
7.4.5.4.China market size and forecast, by type
7.4.5.5.China market size and forecast, by application
7.4.5.6.China market size and forecast, by formulation
7.4.5.7.India market size and forecast, by type
7.4.5.8.India market size and forecast, by application
7.4.5.9.India market size and forecast, by formulation
7.4.5.10.Australia market size and forecast, by type
7.4.5.11.Australia market size and forecast, by application
7.4.5.12.Australia market size and forecast, by formulation
7.4.5.13.Rest of Asia-Pacific market size and forecast, by type
7.4.5.14.Rest of Asia-Pacific market size and forecast, by application
7.4.5.15.Rest of Asia-Pacific market size and forecast, by formulation
7.5.LAMEA
7.5.1.Key market trends and opportunities
7.5.2.LAMEA market size and forecast, by application
7.5.3.LAMEA market size and forecast, by formulation
7.5.4.LAMEA market size and forecast, by country
7.5.4.1.Brazil market size and forecast, by type
7.5.4.2.Brazil market size and forecast, by application
7.5.4.3.Brazil market size and forecast, by formulation
7.5.4.4.South Africa market size and forecast, by type
7.5.4.5.South Africa market size and forecast, by application
7.5.4.6.South Africa market size and forecast, by formulation
7.5.4.7.Rest of LAMEA market size and forecast, by type
7.5.4.8.Rest of LAMEA market size and forecast, by application
7.5.4.9.Rest of LAMEA market size and forecast, by formulation
CHAPTER 8:COMPANY PROFILES
8.1.ALGENOL BIOFUELS INC.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.2.CABASSI & GIURIATI SPA
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.3.CYANOTECH CORPORATION
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.3.6.Key strategic moves and developments
8.4.DDW INC.
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.5.DIC CORPORATION
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.6.DÖHLER GmbH
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.7.DONGTAI CITY SPIRULINA BIO-ENGINEERING CO, LTD.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.8.ECHLORIAL
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.9.E.I.D. PARRY LIMITED
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.10.GIVAUDAN INTERNATIONAL SA
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.11.PROLGAE SPIRULINA SUPPLIES PVT. LTD.
8.11.1.Company overview
8.11.2.Company snapshot
8.11.3.Operating business segments
8.11.4.Product portfolio
8.12.POND TECHNOLOGIES INC.
8.12.1.Company overview
8.12.2.Company snapshot
8.12.3.Operating business segments
8.12.4.Product portfolio
8.13.SENSIENT TECHNOLOGIES CORPORATION
8.13.1.Company overview
8.13.2.Company snapshot
8.13.3.Operating business segments
8.13.4.Product portfolio
8.13.5.Business performance
TABLE 01.CASE STUDY D
TABLE 02.GLOBAL SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027($MILLION)
TABLE 03.GLOBAL SPIRULINA MARKET, BY TYPE, BY PRODUCTION SIDE, 2019–2027($MILLION)
TABLE 04.SPIRULINA MARKET FOR ARTHROSPIRA PLATENSIS, BY REGION, BY CONSUMPTION SIDE, 2019–2027($MILLION)
TABLE 05.SPIRULINA MARKET FOR ARTHROSPIRA MAXIMA, BY REGION, BY CONSUMPTION SIDE, 2019–2027($MILLION)
TABLE 06.GLOBAL SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 07.GLOBAL SPIRULINA MARKET, BY APPLICATION, BY PRODUCTION SIDE, 2019–2027, ($MILLION)
TABLE 08.SPIRULINA MARKET FOR NUTRACEUTICALS, BY CONSUMPTION SIDE, BY REGION, 2019–2027, ($MILLION)
TABLE 09.SPIRULINA MARKET FOR COSMETICS, BY REGION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 10.SPIRULINA MARKET FOR FOOD & BEVERAGES, BY REGION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 11.SPIRULINA MARKET FOR ANIMAL FEED, BY REGION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 12.SPIRULINA MARKET FOR OTHER APPLICATIONS, BY REGION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 13.GLOBAL SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 14.GLOBAL SPIRULINA MARKET, BY FORMULATION, BY PRODUCTION SIDE, 2019–2027, ($MILLION)
TABLE 15.SPIRULINA MARKET FOR POWDER, BY REGION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 16.SPIRULINA MARKET FOR TABLET & CAPSULE, BY REGION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 17.SPIRULINA MARKET FOR LIQUID, BY REGION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 18.SPIRULINA MARKET FOR GRANULE & GELLING AGENT, BY REGION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 19.SPIRULINA MARKET, BY REGION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 20.SPIRULINA MARKET, BY REGION, BY CONSUMPTION SIDE, 2019–2027, (TONS)
TABLE 21.SPIRULINA MARKET, BY REGION, BY PRODUCTION SIDE, 2019–2027, ($MILLION)
TABLE 22.NORTH AMERICA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 23.NORTH AMERICA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 24.NORTH AMERICA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 25.NORTH AMERICA SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 26.NORTH AMERICA SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019–2027, (TONS)
TABLE 27.NORTH AMERICA SPIRULINA MARKET, BY COUNTRY, BY PRODUCTION SIDE, 2019–2027, ($MILLION)
TABLE 28.U.S. SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 29.U.S. SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 30.U.S. SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 31.CANADA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 32.CANADA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 33.CANADA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 34.MEXICO SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 35.MEXICO SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 36.MEXICO SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 37.EUROPE SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 38.EUROPE SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 39.EUROPE SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 40.EUROPE SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 41.EUROPE SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019–2027, (TONS)
TABLE 42.EUROPE SPIRULINA MARKET, BY COUNTRY, BY PRODUCTION SIDE, 2019–2027, ($MILLION)
TABLE 43.GERMANY SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 44.GERMANY SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 45.GERMANY SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 46.FRANCE SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 47.FRANCE SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 48.FRANCE SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 49.UK SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 50.UK SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 51.UK SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 52.ITALY SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 53.ITALY SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 54.ITALY SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 55.SPAIN SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 56.SPAIN SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 57.SPAIN SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 58.REST OF EUROPE SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 59.REST OF EUROPE SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 60.REST OF EUROPE SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 61.ASIA-PACIFIC SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 62.ASIA-PACIFIC SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 63.ASIA-PACIFIC SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 64.ASIA-PACIFIC SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 65.ASIA-PACIFIC SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019–2027, (TONS)
TABLE 66.ASIA-PACIFIC SPIRULINA MARKET, BY COUNTRY, BY PRODUCTION SIDE, 2019–2027, ($MILLION)
TABLE 67.JAPAN SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 68.JAPAN SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 69.JAPAN SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 70.CHINA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 71.CHINA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 72.CHINA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 73.INDIA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 74.INDIA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 75.INDIA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 76.AUSTRALIA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 77.AUSTRALIA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 78.AUSTRALIA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 79.REST OF ASIA-PACIFIC SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 80.REST OF ASIA-PACIFIC SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 81.REST OF ASIA-PACIFIC SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 82.LAMEA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 83.LAMEA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 84.LAMEA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 85.LAMEA SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 86.LAMEA SPIRULINA MARKET, BY COUNTRY, BY CONSUMPTION SIDE, 2019–2027, (TONS)
TABLE 87.LAMEA SPIRULINA MARKET, BY COUNTRY, BY PRODUCTION SIDE, 2019–2027, ($MILLION)
TABLE 88.BRAZIL SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 89.BRAZIL SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 90.BRAZIL SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 91.SOUTH AFRICA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 92.SOUTH AFRICA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 93.SOUTH AFRICA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 94.REST OF LAMEA SPIRULINA MARKET, BY TYPE, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 95.REST OF LAMEA SPIRULINA MARKET, BY APPLICATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 96.REST OF LAMEA SPIRULINA MARKET, BY FORMULATION, BY CONSUMPTION SIDE, 2019–2027, ($MILLION)
TABLE 97.ALGENOL: COMPANY SNAPSHOT
TABLE 98.ALGENOL: OPERATING SEGMENTS
TABLE 99.ALGENOL: PRODUCT PORTFOLIO
TABLE 100.CABASSI & GIURIATI: COMPANY SNAPSHOT
TABLE 101.CABASSI & GIURIATI: OPERATING SEGMENTS
TABLE 102.CYANOTECH: COMPANY SNAPSHOT
TABLE 103.CYANOTECH: OPERATING SEGMENTS
TABLE 104.CYANOTECH: PRODUCT PORTFOLIO
TABLE 105.DDW INC: COMPANY SNAPSHOT
TABLE 106.DDW INC: OPERATING SEGMENTS:
TABLE 107.DDW INC: PRODUCT PORTFOLIO
TABLE 108.DIC: COMPANY SNAPSHOT
TABLE 109.DIC: OPERATING SEGMENTS
TABLE 110.DIC: PRODUCT PORTFOLIO
TABLE 111.DÖHLER: COMPANY SNAPSHOT
TABLE 112.DÖHLER: OPERATING SEGMENTS
TABLE 113.DÖHLER: PRODUCT PORTFOLIO
TABLE 114.DONGTAI: COMPANY SNAPSHOT
TABLE 115.DONGTAI: OPERATING SEGMENTS
TABLE 116.DONGTAI: PRODUCT PORTFOLIO
TABLE 117.ECHLORIAL: COMPANY SNAPSHOT
TABLE 118.ECHLORIAL: OPERATING SEGMENTS
TABLE 119.ECHLORIAL PRODUCT PORTFOLIO
TABLE 120.PARRY: COMPANY SNAPSHOT
TABLE 121.PARRY: OPERATING SEGMENTS
TABLE 122.PARRY: PRODUCT PORTFOLIO
TABLE 123.GIVAUDAN: COMPANY SNAPSHOT
TABLE 124.GIVAUDAN: OPERATING SEGMENTS
TABLE 125.GIVAUDAN: PRODUCT PORTFOLIO
TABLE 126.PROLGAE: COMPANY SNAPSHOT
TABLE 127.PROLGAE: OPERATING SEGMENTS
TABLE 128.PROLGAE SPIRULINA SUPPLIES PVT. LTD: PRODUCT PORTFOLIO
TABLE 129.POND TECHNOLOGIES INC: COMPANY SNAPSHOT
TABLE 130.POND TECHNOLOGIES INC: OPERATING SEGMENTS
TABLE 131.POND TECHNOLOGIES INC: PRODUCT PORTFOLIO
TABLE 132.SENSIENT: COMPANY SNAPSHOT
TABLE 133.SENSIENT: OPERATING SEGMENTS
TABLE 134.SENSIENT: PRODUCT PORTFOLIO
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
